Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/12674
Title: Minimal important difference of the 6-minute walk distance in lung cancer.
Authors: Granger, Catherine L;Holland, Anne E;Gordon, Ian R;Denehy, Linda
Affiliation: Department of Physiotherapy, The University of Melbourne, Parkville, Victoria, Australia Department of Physiotherapy, Royal Melbourne Hospital, Parkville, Victoria, Australia Institute for Breathing and Sleep, Austin Hospital, Heidelberg, Victoria, Australia catherine.granger@unimelb.edu.au.
Institute for Breathing and Sleep, Austin Hospital, Heidelberg, Victoria, Australia Department of Physiotherapy, La Trobe University, Melbourne, Victoria, Australia Department of Physiotherapy, Alfred Hospital, Prahran, Victoria, Australia.
Statistical Consulting Centre, The University of Melbourne, Parkville, Victoria, Australia.
Department of Physiotherapy, The University of Melbourne, Parkville, Victoria, Australia Institute for Breathing and Sleep, Austin Hospital, Heidelberg, Victoria, Australia.
Issue Date: 6-Mar-2015
Citation: Chronic Respiratory Disease 2015; 12(2): 146-54
Abstract: The 6-minute walk distance (6MWD) is one of the most commonly used measures of functional capacity in lung cancer, however, the minimal important difference (MID) has not been established. The aims of this exploratory study are, in lung cancer, to estimate (1) the MID of the 6MWD and (2) relationship between 6MWD, demographic and disease-related factors. Fifty-six participants with stage I-IV lung cancer completed the 6MWD prior to treatment and 10 weeks later. No exercise intervention occurred. Additional measures included European Organization for Research and Treatment of Cancer questionnaire (EORTC-QLQ-C30) and questionnaires assessing function, physical activity and symptoms. MID was calculated using anchor- and distribution-based methods. The mean 6MWD decline in participants classed as deteriorated was 60 m compared with 16 m in participants classed as not-deteriorated (p = 0.01). The receiver operating curve indicated a cut-off value for clinically relevant change to be 42 m (95% confidence interval (CI) 6-75) (area under curve = 0.66, 95% CI 0.51-0.81) or a 9.5% change. Distribution-based methods indicated an MID between 22 m (95% CI 18-26) and 32 m (95% CI 20-42). Higher 6MWD correlated with better function (r = -0.42, p = 0.001), physical activity (r = 0.56, p < 0.005) and dyspnoea (r = -0.44, p = 0.001). The MID for deterioration of the 6MWD in lung cancer is estimated to be between 22 m and 42 m or a change of 9.5%.
Internal ID Number: 25749346
URI: http://ahro.austin.org.au/austinjspui/handle/1/12674
DOI: 10.1177/1479972315575715
URL: http://www.ncbi.nlm.nih.gov/pubmed/25749346
Type: Journal Article
Subjects: 6-minute walk distance (6MWD)
Lung cancer
MID
functional capacity
minimal important difference
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.